Immune Therapeutics competitors

Immune Therapeutics's competitors include Celyad, Aerie Pharmaceuticals, aTyr Pharma and Pernix Therapeutics
Add company...
Immune Therapeutics
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing and distribution of immunotherapies.
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Aerie Pharmaceuticals
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
aTyr Pharma
aTyr Pharma discovers and develops protein biologics for human therapeutics.
Pernix Therapeutics
Pernix Therapeutics develops and markets branded and generic pharmaceutical products for the pediatric market.
Founding Date
Founding Date
2012
Founding Date
2007
Founding Date
2005
Founding Date
2005
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Orlando, US HQ
Locations
Mont-Saint-Guibert, BE HQ
Boston, US
Locations
Irvine, US HQ
Dublin, IE
Bedminster Township, US
Durham, US
Locations
San Diego, US HQ
Locations
Morristown, US HQ
Employees
Employees
10
Employees
794% decrease
Employees
9536% increase
Employees
58
Employees
185
Valuation ($)
Valuation ($)
9.3 m
Valuation ($)
205.7 b
Valuation ($)
2.6 b
Valuation ($)
23.3 m
Valuation ($)
10.8 m
Facebook likes
Facebook likes
187
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
152
Facebook likes
N/A
Twitter followers
Twitter followers
94
Twitter followers
1.6 k
Twitter followers
N/A
Twitter followers
429
Twitter followers
295

Financial

Revenue (est.)
Revenue (est.)
$3.5k (FY, 2016)
Revenue (est.)
€3.5m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$146.1m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
€515k (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$44.6m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
€3m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$101.4m (FY, 2017)
Net income
Net income
($19.8m) (FY, 2016)
Net income
(€56.4m) (FY, 2017)
Net income
($145.1m) (FY, 2017)
Net income
($48.2m) (FY, 2017)
Net income
($77.1m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Celyad
HQ
Mont-Saint-Guibert, BE
Employees
79↓ 4% decrease

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
95↑ 36% increase

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

View company
aTyr Pharma
HQ
San Diego, US
Employees
58

aTyr Pharma discovers and develops protein biologics for human therapeutics.

View company
Pernix Therapeutics
HQ
Morristown, US
Employees
185

Pernix Therapeutics develops and markets branded and generic pharmaceutical products for the pediatric market.

View company